North Florida Regional Medical Center, Inc.

The MaxView 4K System is a towerless visualisation system designed to support ASC environments, with no associated capital equipment costs or impact on operating room space MaxView 4K Imager Camera (Credit: Business Wire/Viseon Inc.) Viseon has commercially rolled out the 4K MaxView System in the US and announced the initial clinical use of the 4K advanced visualisation system for minimally invasive spine surgery. The MaxView 4K System is said to be an enabling, towerless visualisation system for use in an ambulatory surgery centre (ASC) setting without any capital equipment expense or operating room area. It is made up of a reusable, non-sterile 4K Image Control Box and a single-use sterile 4K imaging camera to deliver a real 4K experience on a 4K operating room (OR) monitor for the entire OR team for observation. Viseon, which is a US-based privately held medical device company, said that the digital platform can record real-time surgical videos even as it captures still images. This enables surgeons to create a digital content database for teaching, presentations, publications, reviews of patient cases, and additional analysis using machine learning and artificial intelligence (AI) algorithms to optimise patient outcomes. The MaxView 4K System, which is an implant agnostic, is also said to be compatible with all the major lateral access retractors that are currently on the market. Viseon CEO Jeffrey Valko said: “Enabling advanced minimally invasive spine surgery procedures to be performed in a more safe, efficient and economic manner benefits the patient, the surgeon and the hospital. “Visualisation seems to be such a fundamental requirement during spine surgery but advancing minimally invasive techniques require more advanced visualisation that significantly benefits patient’s safety without a large economic burden on the hospital. Viseon uniquely enables this with the first-ever MaxView 4K System. “We are fortunate to have an exceptionally talented product development team who have repeatably demonstrated their ability to rapidly innovate next generation patented technology enabling us to expand into additional markets such as Neurosurgery, ENT, Endoscopy, and other Orthopaedic uses.” The initial case series with the MaxView 4K system was accomplished by orthopaedic surgeons Rajiv Sethi and Philip Louie at Virginia Mason Medical Center, Seattle, neurosurgeon Alfred Ogden and Valley Hospital, Ridgewood, New Jersey, and orthopaedic surgeon Samuel Joseph at HCA South Tampa Hospital, Tampa, Florida.

HCA Florida Northwest Hospital acquired Anovo for use in transvaginal benign gynecological procedures including hysterectomies. The system represents the first and only FDA-authorized surgical robot with shoulder, elbow and wrist joints, Momentis said. Momentis — formerly Memic Innovative Surgery — designed Anovo (formerly Hominis) to mimic human arms. This allows it to provide human-level dexterity, the company said. “It is essential for surgeons to use the most advanced tools and technologies to ensure we deliver optimal care to our patients, and this system presents several advantages compared to other available robotic technologies,” said Dr. Daniel Gomez, a minimally invasive gynecologic surgeon and assistant program director of the OBGYN Residency Program at HCA Florida Northwest Hospital. “By enabling the transvaginal approach to benign gynecological procedures including benign hysterectomies, we can perform minimally invasive surgery that may deliver benefits including less pain after surgery, leading to a faster recovery, and virtually no visible scarring. “We are also excited to train the next generation of gynecologic surgeons on this new platform to further advance the surgical care that our current OBGYN residents will provide to their patients in the future.” About Anovo from Momentis Surgical Anovo received FDA de novo marketing authorization in February 2021. This authorization covered use in single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures. These include benign hysterectomy, salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal. The system allows for multiple instruments introduced to the body through a single portal. The articulation offers optimal access and working angles. Momentis said Anovo’s transvaginal approach enables benefits such as less patient pain. It also leads to less scarring, shorter recovery times and reduced infection rates. Anovo also requires a smaller footprint and costs less than conventional robotic surgery systems, the company said. “We are pleased to have growing support from leading medical facilities in Florida including HCA Florida Northwest Hospital and hope to continue our momentum as we work to build broader commercial adoption of the Anovo System,” said Dvir Cohen, CEO and co-founder of Momentis.